期刊文献+

直肠高分辨MRI在直肠癌术前分期作用及优势 被引量:10

Role and Advantages of High-resolution MRI in Preoperative Staging of Rectal Cancer
下载PDF
导出
摘要 目的探讨直肠高分辨磁共振成像(MRI)在直肠癌术前分期的作用及优势。方法选取2017年1月至2019年1月确诊的60例直肠癌住院患者,以病理组织学诊断为“金标准”,结合MRI增强扫描结果,对直肠癌患者进行TN分期,比较高分辨MRI直肠癌术前分期情况与病理诊断分期情况。结果高分辨MRI在直肠癌术前分期中T分期准确率为83.33%,Kappa值为0.712(P<0.05);N分期准确率为63.33%,Kappa值为0.391(P<0.05)。结论高分辨MRI对直肠癌术前T分期诊断较为精准,但对N分期诊断率较低。 Objective To investigate the role and advantages of high-resolution magnetic resonance imaging(MRI)in preoperative staging of rectal cancer.Methods Sixty patients with rectal cancer diagnosed from January 2017 to January 2019 were selected.With postoperative histopathological diagnosis as the golden standard,TN staging was performed in patients with rectal cancer according to the results of preoperative MRI enhanced scan images.The preoperative stage of rectal cancer diagnosed by MRI and pathology was compared.Results The accuracy of MRI for preoperative T staging of rectal cancer was 83.33%,and Kappa value was 0.612(P<0.05).The accuracy of N staging was 63.33%,and Kappa value was 0.391(P<0.05).Conclusion MRI can accurately diagnose the preoperative T stage of rectal cancer,but the diagnosis rate of N stage is relatively lower.
作者 冯庆智 龙世亮 赵越 李梅莲 郑儒兴 FENG Qing-zhi;LONG Shi-liang;ZHAO Yue;LI Mei-lian;ZHENG Ru-xing(Department of Radiology,Zhanjiang Central People's Hospital,Zhanjiang 524000,Guangdong Province,China)
出处 《中国CT和MRI杂志》 2021年第7期131-133,共3页 Chinese Journal of CT and MRI
关键词 高分辨磁共振成像 直肠癌 术前分期 High-Resolution Magnetic Resonance Imaging Rectal Cancer Preoperative Staging
  • 相关文献

参考文献12

二级参考文献112

  • 1Zheng Lou,Wei Zhang,Rong-Gui Meng,Chuan-Gang Fu.Massive presacral bleeding during rectal surgery: From anatomy to clinical practice[J].World Journal of Gastroenterology,2013,19(25):4039-4044. 被引量:11
  • 2Ming Li Jin Gu.Changing patterns of colorectal cancer in China over a period of 20 years[J].World Journal of Gastroenterology,2005,11(30):4685-4688. 被引量:93
  • 3Foster JH. Treatment of metastatic disease of the liver: a skeptic's view. Sew-in Liver Dis, 1984,4:170-179.
  • 4Kemeny N. Management of liver metastases from colorectal cancer. Oncology(Williston Park). 2006, 20:1161-1176,1179; discussion 1179-1180, 1155-1166.
  • 5Van Cutsem E, Norlinger B, Adam R, et al. Towards a pan- European consensus on the treatment of patients with colorectal liver metastases. Eur J Cancer, 2006, 6:202-207.
  • 6Bipat S, van Leeuwen MS, Ijzermans JN, et al. Evidencebase guideline on management of colorectal liver metastases in the Netherlands. Neth J Med, 2007,65:5-14.
  • 7Delbeke D, Martin WH. PET and PET-CT for evaluation of colorectal carcinoma. Semin Nucl Med, 2004,34:209-223.
  • 8Jones OM, Rees M, John TG, et al. Biopsy of resectable colorectal liver metastases causes tumour dissemination and adversely affects survival after liver resection. Br J Surg, 2005,92:1165-1168.
  • 9Koshariya M, Jagad RB, Kawamoto J, et al. An update and our experience with metastatic liver disease. Hepatogastroen- terology, 2007, 54:2232-2239.
  • 10Desch CE,Benson AB,Somerfield MR,et al. Colorectal cancer surveillance: 2005 update of an American Society of Clinical Oncology practice guideline. J Clin Oncol, 2005, 23:8512-8519.

共引文献571

同被引文献103

引证文献10

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部